异动解读｜康希诺生物盘中下跌5.4%，中期业绩发布后短期获利回吐压力延续

行情直击08-28

8月28日，康希诺生物盘中下跌5.4%，报33.3港元，成交额7712.74万港元。

消息面上，公司8月27日晚间披露中期业绩：上半年实现营业收入5.50亿元，同比增长43.81%；归母净亏损72.08万元，较上年同期亏损1348.54万元大幅收窄94.65%；海外收入1.5亿元，同比增长超47倍。业绩表现积极，但此前受Moderna mRNA癌症疫苗三期临床成功及公司与德普世生物签署肿瘤疫苗合作协议等多重利好驱动，公司A股三日累涨逾30%、H股单日大涨逾16%，短期累计涨幅较大，获利盘兑现压力持续释放，8月27日已回调逾5%，今日延续回吐走势。

（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/1147675691?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-28 09:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147675691","market":"us","top_or_hot":-1,"title":"异动解读｜康希诺生物盘中下跌5.4%，中期业绩发布后短期获利回吐压力延续","media":"行情直击","content":"<p><p>8月28日，康希诺生物盘中下跌5.4%，报33.3港元，成交额7712.74万港元。</p><p>消息面上，公司8月27日晚间披露中期业绩：上半年实现营业收入5.50亿元，同比增长43.81%；归母净亏损72.08万元，较上年同期亏损1348.54万元大幅收窄94.65%；海外收入1.5亿元，同比增长超47倍。业绩表现积极，但此前受Moderna mRNA癌症疫苗三期临床成功及公司与德普世生物签署肿瘤疫苗合作协议等多重利好驱动，公司A股三日累涨逾30%、H股单日大涨逾16%，短期累计涨幅较大，获利盘兑现压力持续释放，8月27日已回调逾5%，今日延续回吐走势。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜康希诺生物盘中下跌5.4%，中期业绩发布后短期获利回吐压力延续</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜康希诺生物盘中下跌5.4%，中期业绩发布后短期获利回吐压力延续\n</h2>\n\n<h4 class=\"meta\">\n\n2026-08-28 09:43 北京时间&nbsp;&nbsp;&nbsp;<strong>行情直击</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月28日，康希诺生物盘中下跌5.4%，报33.3港元，成交额7712.74万港元。消息面上，公司8月27日晚间披露中期业绩：上半年实现营业收入5.50亿元，同比增长43.81%；归母净亏损72.08万元，较上年同期亏损1348.54万元大幅收窄94.65%；海外收入1.5亿元，同比增长超47倍。业绩表现积极，但此前受Moderna mRNA癌症疫苗三期临床成功及公司与德普世生物签署肿瘤疫苗合作...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"","article_id":"1147675691","we_media_id":"1059448697","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147675691","pubTimestamp":1787881397,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"行情直击","introduction":"个股异动一手消息解读","home_visible":1,"id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"8月28日，康希诺生物盘中下跌5.4%，报33.3港元，成交额7712.74万港元。业绩表现积极，但此前受Moderna mRNA癌症疫苗三期临床成功及公司与德普世生物签署肿瘤疫苗合作协议等多重利好驱动，公司A股三日累涨逾30%、H股单日大涨逾16%，短期累计涨幅较大，获利盘兑现压力持续释放，8月27日已回调逾5%，今日延续回吐走势。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06185":"康希诺生物"},"translate_title":"Analysis of Unusual Movements | CanSino Biologics fell 5.4% intraday as short-term profit-taking pressure continued after the release of its interim results.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1},"content_text":"8月28日，康希诺生物盘中下跌5.4%，报33.3港元，成交额7712.74万港元。消息面上，公司8月27日晚间披露中期业绩：上半年实现营业收入5.50亿元，同比增长43.81%；归母净亏损72.08万元，较上年同期亏损1348.54万元大幅收窄94.65%；海外收入1.5亿元，同比增长超47倍。业绩表现积极，但此前受Moderna mRNA癌症疫苗三期临床成功及公司与德普世生物签署肿瘤疫苗合作协议等多重利好驱动，公司A股三日累涨逾30%、H股单日大涨逾16%，短期累计涨幅较大，获利盘兑现压力持续释放，8月27日已回调逾5%，今日延续回吐走势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147675691","isCrawlerRequest":true}